Product
CanniMed
1 clinical trial
1 indication
Indication
Epileptic EncephalopathyClinical trial
Cannabidiol in Children With Refractory Epileptic Encephalopathy: A Phase 1 Open Label Dose Escalation Study (CARE-E)Status: Active (not recruiting), Estimated PCD: 2020-02-01